Legend Biotech (LEGN) Inventory (2019 - 2026)
Legend Biotech's (LEGN) quarterly Inventory came in at $37.1 million in Q1 2026, up 19.94% YoY from $30.9 million in Q1 2025, and up 15.94% on a QoQ basis from $32.0 million in Q4 2025.
Legend Biotech (LEGN) Inventory (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 8 years of Inventory data on file, last reported at $37.1 million in Q1 2026.
- Quarterly Inventory rose 19.94% year-over-year to $37.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.1 million (up 19.94% YoY) and the FY2025 annual result came in at $32.0 million, up 33.89% from the prior year.
- Inventory improved to $37.1 million in Q1 2026, from $32.0 million in the prior quarter.
- In the past five years, Inventory ranged from a high of $37.1 million in Q1 2026 to a low of $2.9 million in Q1 2022.
- A 5-year average of $22.1 million and a median of $22.1 million in 2024 frame the typical range for Inventory.
- Annual changes were most pronounced in 2022 — Inventory jumped 137954.36% — and 2026, when it gained 19.94%.
- Tracing LEGN's Inventory over 5 years: stood at $10.4 million in 2022, then jumped by 87.69% to $19.4 million in 2023, then advanced by 22.99% to $23.9 million in 2024, then jumped by 33.89% to $32.0 million in 2025, then increased by 15.94% to $37.1 million in 2026.
- The last three Inventory figures came in at $37.1 million (Q1 2026), $32.0 million (Q4 2025), and $29.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | 41.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.50 Mn |
| Mar 31, 2026 | 37.10 Mn |
| Dec 31, 2025 | 32.00 Mn |
| Sep 30, 2025 | 29.18 Mn |
| Jun 30, 2025 | 35.59 Mn |
| Mar 31, 2025 | 30.93 Mn |
| Dec 31, 2024 | 23.90 Mn |
| Sep 30, 2024 | 23.55 Mn |
| Jun 30, 2024 | 18.87 Mn |
| Mar 31, 2024 | 22.15 Mn |
| Dec 31, 2023 | 19.43 Mn |
| Sep 30, 2023 | 18.01 Mn |
| Jun 30, 2023 | 15.20 Mn |
| Mar 31, 2023 | 12.18 Mn |
| Dec 31, 2022 | 10.35 Mn |
| Mar 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 1.63 Mn |
| Jun 30, 2021 | 1,700.00 |
| Mar 31, 2021 | 2,097.00 |